WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MIRM

Based on 13 analysts offering 12 month price targets for Mirum Pharmaceuticals Inc

Min Forecast
$125.00+33.38%
Avg Forecast
$154.39+64.73%
Max Forecast
$202.00+115.54%

Should I buy or sell MIRM stock?

Based on 13 analysts offering ratings for Mirum Pharmaceuticals Inc.

Strong Buy
Strong Buy
6 analysts 46.15%
Buy
7 analysts 53.85%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MIRM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MIRM as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their MIRM stock forecasts and price targets.

MIRM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-11-05
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04
TD Cowen
Bottom 5%
5
Strong BuyMaintains$145.00+54.72%2026-10-21
Stifel Nicolaus
Bottom 13%
13
Strong BuyMaintains$156.00+66.45%2026-10-15
Evercore ISI Group
Bottom 16%
16
BuyMaintains$146.00+55.78%2026-10-13
Morgan Stanley
Top 17%
84
Strong BuyMaintains$152.00+62.19%2026-10-13Find out why
Citigroup
Top 11%
90
Strong BuyMaintains$184.00+96.33%2026-10-12Find out why

1 of 2

Forecast return on equity

Is MIRM forecast to generate an efficient return?

Company
-693.7%
Industry
8.83%
Market
167.36%
MIRM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MIRM forecast to generate an efficient return on assets?

Company
36.61%
Industry
20.04%
MIRM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MIRM earnings per share forecast

What is MIRM's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$15.48
Avg 2 year Forecast
-$0.65
Avg 3 year Forecast
$2.16

MIRM revenue forecast

What is MIRM's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$712.0M+6.15%
Avg 2 year Forecast
$834.5M+24.41%
Avg 3 year Forecast
$1.1B+61.45%
MIRM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MIRM revenue growth forecast

How is MIRM forecast to perform vs Biotechnology companies and vs the US market?

Company
16.39%
Industry
29.74%
Market
12.09%
MIRM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MIRM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MIRM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MIRM$93.72$154.39+64.73%Strong Buy
LGND$306.20$354.75+15.86%Strong Buy
BLTE$154.19$251.60+63.18%Strong Buy
KOD$99.30$92.33-7.02%Strong Buy
IMVT$30.53$47.67+56.13%Strong Buy
View Top Biotech Stocks

Mirum Pharmaceuticals Stock Forecast FAQ

Is Mirum Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NASDAQ: MIRM) stock is to Strong Buy MIRM stock.

Out of 13 analysts, 6 (46.15%) are recommending MIRM as a Strong Buy, 7 (53.85%) are recommending MIRM as a Buy, 0 (0%) are recommending MIRM as a Hold, 0 (0%) are recommending MIRM as a Sell, and 0 (0%) are recommending MIRM as a Strong Sell.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.

What is MIRM's earnings growth forecast for 2026-2028?

(NASDAQ: MIRM) Mirum Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.04%.

Mirum Pharmaceuticals's earnings in 2026 is -$903,878,000.On average, 17 Wall Street analysts forecast MIRM's earnings for 2026 to be -$1,010,389,780, with the lowest MIRM earnings forecast at -$1,112,484,368, and the highest MIRM earnings forecast at -$937,025,819. On average, 17 Wall Street analysts forecast MIRM's earnings for 2027 to be -$42,570,421, with the lowest MIRM earnings forecast at -$182,332,749, and the highest MIRM earnings forecast at $106,383,619.

In 2028, MIRM is forecast to generate $140,943,933 in earnings, with the lowest earnings forecast at $14,714,573 and the highest earnings forecast at $369,809,723.

What is MIRM's revenue growth forecast for 2026-2028?

(NASDAQ: MIRM) Mirum Pharmaceuticals's forecast annual revenue growth rate of 16.39% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 29.74%, and while it is forecast to beat the US market's average forecast revenue growth rate of 12.09%.

Mirum Pharmaceuticals's revenue in 2026 is $670,778,000.On average, 16 Wall Street analysts forecast MIRM's revenue for 2026 to be $46,480,815,328, with the lowest MIRM revenue forecast at $43,840,809,469, and the highest MIRM revenue forecast at $48,565,270,993. On average, 15 Wall Street analysts forecast MIRM's revenue for 2027 to be $54,478,518,538, with the lowest MIRM revenue forecast at $47,997,317,210, and the highest MIRM revenue forecast at $60,492,300,432.

In 2028, MIRM is forecast to generate $70,700,453,652 in revenue, with the lowest revenue forecast at $61,777,703,878 and the highest revenue forecast at $79,709,375,724.

What is MIRM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MIRM) forecast ROA is 36.61%, which is higher than the forecast US Biotechnology industry average of 20.04%.

What is MIRM's Price Target?

According to 13 Wall Street analysts that have issued a 1 year MIRM price target, the average MIRM price target is $154.39, with the highest MIRM stock price forecast at $202.00 and the lowest MIRM stock price forecast at $125.00.

On average, Wall Street analysts predict that Mirum Pharmaceuticals's share price could reach $154.39 by Nov 5, 2027. The average Mirum Pharmaceuticals stock price prediction forecasts a potential upside of 64.73% from the current MIRM share price of $93.72.

What is MIRM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MIRM) Mirum Pharmaceuticals's current Earnings Per Share (EPS) is -$15.23. On average, analysts forecast that MIRM's EPS will be -$15.48 for 2026, with the lowest EPS forecast at -$17.04, and the highest EPS forecast at -$14.35. On average, analysts forecast that MIRM's EPS will be -$0.65 for 2027, with the lowest EPS forecast at -$2.79, and the highest EPS forecast at $1.63. In 2028, MIRM's EPS is forecast to hit $2.16 (min: $0.23, max: $5.66).

What is MIRM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MIRM) forecast ROE is -693.7%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.